National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 3,619 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 22 out of 362

Result pages: prev   13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31   next


VAERS ID: 1112896 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-09
Onset:2021-01-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute respiratory failure, Blood pH, Body temperature, COVID-19, Incorrect route of product administration, Oxygen saturation, Pyrexia, SARS-CoV-2 test positive
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Drug abuse and dependence (broad), Acute central respiratory depression (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-24
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210121; Test Name: Body temperature; Result Unstructured Data: Test Result:Fever; Test Date: 20210121; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Positive; Test Date: 202101; Test Name: saturation; Test Result: 90 %; Test Date: 202101; Test Name: pH value; Result Unstructured Data: Test Result:6.8
CDC Split Type: DEPFIZER INC2021267002

Write-up: Acute respiratory failure; COVID-19; Fever; Comirnaty was administered via subcutaneous route; This is a spontaneous report from a non-contactable consumer downloaded from Regulatory Authority-WEB DE-PEI-CADR2021015865. An 84-year-old female patient received the first dose of bnt162b2 (COMIRNATY) (Batch/Lot Number: Unknown) subcutaneous on 09Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Jan2021 the patient experienced fever, acute respiratory failure, COVID-19. The outcome for fever and COVID-19 was unknown, the outcome for acute respiratory failure was fatal. The patient underwent lab tests and procedures which included SARS-CoV2 test: positive on 21Jan2021. The patient died on 24Jan2021. An autopsy was not performed. Sender Comment: The current admission took place in COVID intensive care unit, accompanied by the emergency doctor. The emergency doctor reports that the patient developed a fever about a week ago with a known SARS-CoV2 infection. The patient had previously been vaccinated for the first time on 09Jan2021. A home resident had previously tested positive for SARS CoV2. When the emergency doctor arrived, the patient was already respiratory unstable with an SO2 of 50%. After NIV ventilation the saturation was 90%. Upon arrival at our hospital, we saw a cardiorespiratory unstable patient. The BGA showed global respiratory insufficiency with a pH value of 6.8. Within 5 minutes of her arrival, the patient was gasped and required resuscitation. The resuscitation remained frustrated. The patient died on 24Jan2021 at 7:19 a.m.". Causality from Regulatory Authority: Inconsistent causal association to immunization for all events. No follow-up attempts needed, follow-up automatically provided by Regulatory Authority.; Reported Cause(s) of Death: Acute respiratory failure


VAERS ID: 1112903 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-03
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Drug ineffective, SARS-CoV-2 test positive
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Covid-Test; Test Result: Positive
CDC Split Type: DEPFIZER INC2021267018

Write-up: Unknown cause of death; COVID-19; COVID-19; This is a spontaneous report received from a contactable consumer downloaded from the Regulatory Authority, regulatory authority number DE-PEI-CADR2021018352. An elderly patient of an unspecified age and gender received the BNT162B2 (COMIRNATY, lot number unknown), via an unspecified route of administration, on 03Jan2021 at single dose, for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced COVID-19, and unknown cause of death. It was not reported if an autopsy was performed. The patient underwent lab tests and procedures, which included COVID test was positive on an unknown date. The outcome of the event "unknown cause of death" was fatal, of event "COVID-19" was not recovered. Sender Comment: 7x Covid infections after 1st dose, 1 of which is fatal; 10x Covid infections after the 2nd dose, 6 of them fatal up to 10 days after the 2nd dose. A variant PCR was commissioned in five cases, and two results are now available: In both cases, no mutation was detected. Cluster report. Causality: Inconsistent causal association to immunization No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1112923 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-27
   Days after vaccination:22
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6796 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Respiratory failure, SARS-CoV-2 test, Severe acute respiratory syndrome
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (broad), Respiratory failure (narrow), Infective pneumonia (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-18
   Days after onset: 22
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Exposure to COVID-19 (close contact of confirmed cases); Living in residential institution
Allergies:
Diagnostic Lab Data: Test Date: 20210127; Test Name: COVID-19 antigen test; Test Result: Positive ; Test Date: 20210122; Test Name: COVID-19 PCR test; Test Result: Negative ; Test Date: 20210209; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ESPFIZER INC2021261515

Write-up: Severe acute respiratory syndrome; Respiratory insufficiency; COVID-19/severe acute respiratory syndrome/ respiratory insufficiency; COVID-19; This is a spontaneous report downloaded from the Regulatory Authority-WEB (ES-AEMPS-775868). A contactable physician reported that a 86-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 05Jan2021 (first dose, lot EJ6796) at single dose, and via an unspecified route of administration on 12Feb2021 (second dose, lot unknown) at single dose for covid-19 immunization. Medical history included being institutionalized, exposure to COVID-19 from Feb2021 (close contact of confirmed cases). The patient''s concomitant medications were not reported. The patient experienced covid-19 on 27Jan2021, and severe acute respiratory syndrome/ respiratory insufficiency on 16Feb2021. Ambulance was notified of severe acute respiratory syndrome associated with coronavirus. The patient underwent lab tests included COVID-19 PCR test: negative on 22Jan2021, COVID-19 PCR test: positive on 09Feb2021 with antibodies not performed, COVID-19 antigen test: positive on 27Jan2021. Outcome of events was fatal. The patient died on 18Feb2021. It was not reported if an autopsy was performed. The cause of death included drug ineffective, COVID-19, severe acute respiratory syndrome, respiratory insufficiency. This notification also informed that of the possibility of a post-vaccination reaction event to the second dose that was administered on 12Feb2021. The evaluation after reviewing and expanding the available information, considered that the verification of a previous positive Active Infection Diagnostic Test, a positive PCR prior to the events reported and the clinical judgment of severe acute respiratory disease associated with coronavirus, allowed establishing a relationship between the reported event with covid infection in a patient with incomplete immunization. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Respiratory insufficiency; covid-19; Severe acute respiratory syndrome; COVID-19/severe acute respiratory syndrome/ respiratory insufficiency


VAERS ID: 1113080 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-01-26
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Oxygen saturation, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-18
   Days after onset: 23
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Hip prosthesis user
Allergies:
Diagnostic Lab Data: Test Date: 20210126; Test Name: body temperature; Result Unstructured Data: Test Result:fever; Test Date: 20210126; Test Name: oxygen desaturation; Result Unstructured Data: Test Result:oxygen desaturation; Test Date: 20210126; Test Name: COVID-19 Testing; Result Unstructured Data: Test Result:aggravated COVID-19
CDC Split Type: FRPFIZER INC2021272392

Write-up: COVID-19 aggravated; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority FR-AFSSAPS-MP20210365. An 89-year-old male patient received first dose of bnt162b2 (COMIRNATY, Batch/Lot Number: EJ6788), intramuscular, in Arm Left on 21Jan2021 at single dose (reported as 1 DF) for covid-19 immunisation. Medical history included Hip prosthesis user and COVID-19. The patient''s concomitant medications were not reported. The patient experienced covid-19 aggravated on 26Jan2021, serious due to resulted in death. Therapeutic measures were taken as a result of covid-19 aggravated (covid-19). The patient died on 18Feb2021. An autopsy was not performed. The clinical course was reported as follows: Reporting via national website from a healthcare professional. Patient considered to be at risk of developing severe COVID-19. The patient had history of COVID-19. Testing was done on 26Jan2021. Course of the events: The patient was vaccinated in the framework of anti-COVID-19 vaccination plan. The first injection was performed with COVID-19 mRNA Vaccine (nucleoside modified) (COMIRNATY), lot #EJ6788 by intramuscular route in the left arm on 21Jan2021. On 26Jan2021, the patient was diagnosed with aggravated COVID-19 with fever and oxygen desaturation. On 03Feb2021, oxygen (unspecified trade name) therapy and IV fluids were given. From 09Feb2021, the patient presented with appetite loss, refusal of feeding and urinary retention. On 18Feb2021, the patient died. The conclusion was aggravated COVID-19 leading to death 28 days following vaccination. No other information was available. No FU attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 aggravated


VAERS ID: 1113785 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2020-12-18
Onset:2021-01-03
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-22
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Acute on chronic renal failure; Chronic kidney disease; Hypercholesterolaemia; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210103; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021263133

Write-up: COVID-19; COVID-19; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Agency. Regulatory authority report number GB-MHRA-WEBCOVID-202103071730497410, Safety Report Unique Identifier GB-MHRA-ADR 24895167. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/lot number: Not known), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 vaccination. Medical history included acute kidney injury, hypertension, chronic kidney disease and hypercholesterolaemia all unknown if ongoing, Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced covid-19 on 03Jan2021. The patient underwent lab tests and procedures which included COVID-19 virus test: yes - positive covid-19 test on 03Jan2021. The patient died of covid-19 on 22Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19; COVID-19


VAERS ID: 1113852 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-01
Onset:2021-02-02
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, COVID-19, Chills, Fatigue, Malaise, Myalgia, Pyrexia, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Heart failure; Pulmonary hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210203; Test Name: pyrexia; Result Unstructured Data: Test Result:Fever: 38 to 40.5 degrees Celsius Centigrade; Test Date: 20210204; Test Name: SARS CoV 2 test; Test Result: Positive
CDC Split Type: NLPFIZER INC2021256546

Write-up: Myalgia; Chills; Pain in the joints; Corona test / positive three days after first vaccination; Not feeling well; Fatigue; Fever: 38 to 40.5 degrees Celsius; This is a spontaneous report from a contactable consumer downloaded from the Agency Regulatory Authority-WEB (NL-LRB-00461135). An 82-year-old male patient received the first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration, on 01Feb2021 at single dose for COVID-19 immunisation. Relevant medical history included pulmonary hypertension and heart failure. The patient was receiving unspecified concomitant medications. On 02Feb2021, the patient was not feeling well, she had fatigue and fever: 38 to 40.5 degrees Celsius. On 04Feb2021, the patient developed myalgia, chills and pain in the joints. These events led to patient''s death in 2021. On 04Feb2021, SARS-COV-2 test was done and resulted positive. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Fatigue; Fever: 38 to 40.5 degrees Celsius; Myalgia; Chills; Pain in the joints; Covid-19; Not feeling well


VAERS ID: 1113896 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ROPFIZER INC2021273255

Write-up: became infected with COVID-19, had a severe form of COVID-19 and then died; became infected with COVID-19, had a severe form of COVID-19 and then died; This is a spontaneous report from a contactable ICU physician. This report was received via a sales representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number not provided), first dose and second dose both via unspecified route of administration on unknown date (at unknown age) at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. A female patient who was vaccinated anti COVID-19 with both doses, became infected with COVID-19, had a severe form of COVID-19 and then died on unknown date. It is not known which COVID-19 vaccine was administered. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Drug causality for suspect drug in the onset of the reported events cannot be excluded assuming a plausible temporal association in a context of LOE. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: became infected with COVID-19, had a severe form of COVID-19 and then died; became infected with COVID-19, had a severe form of COVID-19 and then died


VAERS ID: 1114005 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-09
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Death, Decreased appetite, Dehydration, Diarrhoea, Gastrointestinal pain, Hypotension, Incorrect route of product administration, Nausea, Oliguria, Pyrexia, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Drug abuse and dependence (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow), Tumour lysis syndrome (broad), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (narrow), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-16
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Adipositas; Apoplexy; Arterial hypertension (Under treatment); Atrial fibrillation; Heart valve replacement NOS; Polyarthralgia
Preexisting Conditions: Medical History/Concurrent Conditions: Hashimoto''s thyroiditis
Allergies:
Diagnostic Lab Data: Test Date: 20210110; Test Name: Body temperature; Result Unstructured Data: Test Result:Fever; Test Date: 20210116; Test Name: COVID-19 test; Test Result: Positive
CDC Split Type: DEPFIZER INC2021266963

Write-up: Tested positive for COVID-19; Exsiccosis; Oliguria; Gut pain; Pyrexia; Nausea; Appetite lost; Diarrhoea; Hypotension; Unknown cause of death; BNT162b2 (COMIRNATY), intravenous; This is a spontaneous report from a non-contactable consumer, downloaded from the Regulatory Authority (regulatory authority number DE-PEI-CADR2021014173). A 75-year-old female patient received a single dose of BNT162b2 (COMIRNATY), intravenous, on 09Jan2021, for COVID-19 immunisation. The patient''s medical history included ongoing polyarthralgia, ongoing adipositas, ongoing cardiac valve replacement, ongoing apoplexy, ongoing atrial fibrillation, Hashimoto-Thyreoiditis, and ongoing hypertension. The patient''s concomitant medications included unspecified anti-hypertensive drug(s). The patient previously took Phenprocoumon (MARCUMAR) as anticoagulant therapy. On 10Jan2021 the patient experienced gut (abdominal) pain, fever, nausea, loss of appetite, and diarrhea (described as liquid stool). On 12Jan2021 the patient experienced deterioration with diarrhea, exsiccosis, and oliguria. On 15Jan2021, the patient was treated with infusions, and her hypertensive medication was reduced due to hypotension; the patient was hospitalized. On 16Jan2021, the patient tested positive for COVID-19. On 16Jan2021 the patient died, however the cause of death was not provided. No autopsy was performed. The patient had not recovered from diarrhea, exsiccosis, oliguria, while the outcome of the other events was unknown. Sender Comment: Arterial hypertension, adipositas, atrial fibrillation, anticoagulation with Marcumar, condition after cardiac valve replacement, polyarthrosis, Hashimoto-Thyreoiditis, condition after apoplexy. On 09Jan2021 vaccination COVID-19, on 10Jan2021 abdominal pain, fever, nausea, loss of appetite, liquid stool, 12Jan2021 deterioration with diarrhea, exsiccosis, oliguria; Therapy with infusions, reduction of hypertensive medication due to hypotension, on 15Jan2021 Hospitalization, positve test for Covid-19, on 16Jan2021 Exsitus letalis Causality has been assessed as "D. Unclassifiable " for all events by the Facility. No follow-up attempts needed, follow-up automatically provided by Regulatory Authority.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1114009 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-23
Onset:2021-01-26
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Respiratory distress, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-31
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asymptomatic COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20210129; Test Name: PCR smear; Result Unstructured Data: Test Result:unknown results; Comments: PCR result is not yet available; Test Date: 20210127; Test Name: rapid test; Test Result: Positive
CDC Split Type: DEPFIZER INC2021266931

Write-up: 27Jan2021 positive rapid test; Respiratory distress; This is a spontaneous report from a non-contactable consumer downloaded from the Regulatory Authority-WEB regulatory authority number DE-PEI-CADR2021015257. A 90-year-old female patient received bnt162b2 (COMIRNATY, lot number unknown), via intramuscular on 23Jan2021 at single dose for COVID-19 immunisation. The relevant medical history included asymptomatic COVID-19 from 27Dec2020. Concomitant medications were not reported. On 26Jan2021 the patient experienced breathing difficulties and respiratory distress. The patient had rapid test positive on 27Jan2021. The patient died on 31Jan2021. No autopsy was done. The patient underwent lab test included rapid test which showed positive on 27Jan2021; PCR smear with unknown results (PCR result is not yet available) on 29Jan2021. The outcome of the event respiratory distress was fatal, while other events were unknown. Sender Comment: Presumably the time of infection was 1-2 days before vaccination, 23Jan2021 first vaccination, 26Jan2021 first symptoms, 27Jan2021 positive rapid test, 29Jan2021 PCR smear, 31Jan2021 died, PCR result is not yet available. Information about lot/batch number cannot be obtained. No further information expected.; Reported Cause(s) of Death: Respiratory distress


VAERS ID: 1114050 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-01-30
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, N-terminal prohormone brain natriuretic peptide, Oxygen saturation, Physical examination, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-19
   Days after onset: 20
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anaemia macrocytic; COVID-19; Dementia; Starvation
Allergies:
Diagnostic Lab Data: Test Name: N-terminal prohormone brain natriuretic peptide; Result Unstructured Data: Test Result:increase; Test Date: 20210130; Test Name: oxygen saturation; Result Unstructured Data: Test Result:desaturation; Test Name: crackles heard; Result Unstructured Data: Test Result:increased crackles heard over lower lung fields; Test Date: 20210130; Test Name: tested for COVID-19 on 30Jan2021; Result Unstructured Data: Test Result:COVID-19 aggravation
CDC Split Type: FRPFIZER INC2021272389

Write-up: COVID-19 aggravated; This is a spontaneous report from a contactable physician via Agency downloaded from the Regulatory Authority FR-AFSSAPS-MP20210366 A 97-years-old male patient received the first dose of bnt162b2 (COMIRNATY Batch/Lot Number: EJ6788), intramuscular, administered in Arm Right on 21Jan2021 as single dose for covid-19 immunisation. Medical history included starvation, dementia and anaemia macrocytic all unknown if ongoing. The patient had medical history of COVID-19 and was considered at risk of developing a severe form of COVID-19. The patient''s concomitant medications were not reported. The patient experienced covid-19 aggravated on 30Jan2021 with fatal outcome. The patient died on 19Feb2021. An autopsy was not performed. The clinical course of the events was reported as follows. On 30Jan2021, the patient presented dyspnea, fever and oxygen desaturation which required oxygen therapy was tested for COVID-19 on 30Jan2021 and was diagnosed with COVID-19 aggravation. The patient then presented worsening of confusion and agitation, increased crackles heard over lower lung fields and increase of N-terminal prohormone brain natriuretic peptide, asthenia and anorexia. Outcome: On 19Feb2021, 29 days after vaccination, the patient died due to COVID-19 aggravation. Complete file, no further information available.; Reported Cause(s) of Death: COVID-19 aggravated


Result pages: prev   13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=22&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166